Being a R&D company with a limited footprint Hi All,
its been a while since I posted.
We are due for another update from our bespoke Exec team on all fronts. The term "care and maintenance" doesnt sit well with me as a shareholder. Don't get me wrong I am all for taking precautions to spread covid 19 BUT its not a excuse to significantly slow things down for ECT.
Working from home for office staff should yield efficiency savings, the construction industry is still blazing on all cylinders. And most of the stakeholder management can be done on-line.
Where are we at with our targets? When can shareholders expect a return on the investment?
ECT - where are you
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ECT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.515M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3.469K | 1.156M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 19513067 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 11596834 | 27 |
View Market Depth
| Last trade - 15.57pm 21/06/2024 (20 minute delay) ? |
| ECT (ASX) Chart |